Could this really be a BIG breakthrough?

› Forums › General Melanoma Community › Could this really be a BIG breakthrough?

  • Post
Viewing 5 reply threads
  • Replies
      • November 15, 2011 at 3:49 pm
      MichaelFL
      Participant

        Take this with a grain of salt for now. MUC1 was first defined as a tumor antigen in the late 1980s. Overexpression of MUC1 is often associated with colon, breast, ovarian, lung and pancreatic cancers. There are currently trials in the U.S. as well. Mainly for breast and colon cancer.

        If we had a nickel for every company CEO that said they had a potential cure, we'd all be rich.

          • November 15, 2011 at 6:46 pm
          lablover
          Participant

            I agree with where you are coming from in terms of taking with a grain of salt for now but, the article clearly states that, "more than 90% of different cancers have MUC1 on their cells, which indicates the potential for this vaccine." 90% is a lot more than the few cancers you mentioned. 

            It's still a ways off (six years according to the article) and the clinical trials do not include melanoma but it still sounds very promising if it's all true.

            • November 15, 2011 at 6:46 pm
            lablover
            Participant

              I agree with where you are coming from in terms of taking with a grain of salt for now but, the article clearly states that, "more than 90% of different cancers have MUC1 on their cells, which indicates the potential for this vaccine." 90% is a lot more than the few cancers you mentioned. 

              It's still a ways off (six years according to the article) and the clinical trials do not include melanoma but it still sounds very promising if it's all true.

              • November 15, 2011 at 6:46 pm
              lablover
              Participant

                I agree with where you are coming from in terms of taking with a grain of salt for now but, the article clearly states that, "more than 90% of different cancers have MUC1 on their cells, which indicates the potential for this vaccine." 90% is a lot more than the few cancers you mentioned. 

                It's still a ways off (six years according to the article) and the clinical trials do not include melanoma but it still sounds very promising if it's all true.

              • November 15, 2011 at 3:49 pm
              MichaelFL
              Participant

                Take this with a grain of salt for now. MUC1 was first defined as a tumor antigen in the late 1980s. Overexpression of MUC1 is often associated with colon, breast, ovarian, lung and pancreatic cancers. There are currently trials in the U.S. as well. Mainly for breast and colon cancer.

                If we had a nickel for every company CEO that said they had a potential cure, we'd all be rich.

                • November 15, 2011 at 3:49 pm
                MichaelFL
                Participant

                  Take this with a grain of salt for now. MUC1 was first defined as a tumor antigen in the late 1980s. Overexpression of MUC1 is often associated with colon, breast, ovarian, lung and pancreatic cancers. There are currently trials in the U.S. as well. Mainly for breast and colon cancer.

                  If we had a nickel for every company CEO that said they had a potential cure, we'd all be rich.

                  • November 16, 2011 at 12:43 am
                  JerryfromFauq
                  Participant

                    There is a remote possibility that this could be big.  BUT it sounds a  lot like the early talk about Zelboraf. which has dropped from early talk of 80% down to often  short term aid for around 25% of certain groups of melanoma patients and near zero for other groups.  Not holding my breath, but hoping not too many paths around this possibility are found by melanoma.

                    • November 16, 2011 at 12:43 am
                    JerryfromFauq
                    Participant

                      There is a remote possibility that this could be big.  BUT it sounds a  lot like the early talk about Zelboraf. which has dropped from early talk of 80% down to often  short term aid for around 25% of certain groups of melanoma patients and near zero for other groups.  Not holding my breath, but hoping not too many paths around this possibility are found by melanoma.

                      • November 16, 2011 at 12:43 am
                      JerryfromFauq
                      Participant

                        There is a remote possibility that this could be big.  BUT it sounds a  lot like the early talk about Zelboraf. which has dropped from early talk of 80% down to often  short term aid for around 25% of certain groups of melanoma patients and near zero for other groups.  Not holding my breath, but hoping not too many paths around this possibility are found by melanoma.

                    Viewing 5 reply threads
                    • You must be logged in to reply to this topic.
                    About the MRF Patient Forum

                    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

                    Popular Topics